A Critical Appraisal of Lipid Nanoparticles Deployed in Cancer Pharmacotherapy

Area of Science:

• Oncology
• Nanotechnology
• Pharmaceutics

Background:

• Cancer treatment faces challenges with traditional drug delivery, including poor pharmacokinetics and high systemic toxicity.
• Novel drug delivery strategies are crucial for improving the efficacy of anticancer therapeutics.
• Nanotechnology-based systems, particularly lipid nanocarriers, show significant promise in overcoming these limitations.

Purpose of the Study:

• To critically assess various lipid nanocarrier systems for effective anticancer drug delivery.
• To review synthesis approaches for laboratory and commercial development of lipid nanocarriers.
• To illustrate the application of lipid nanocarriers in cancer therapy and evaluate their safety and toxicity.

Main Methods:

• Systematic review of literature on lipid nanocarrier systems for anticancer drug delivery.
• Analysis of diverse synthesis methodologies for lipid nanocarriers.
• Evaluation of preclinical and clinical data on the application, safety, and toxicity of lipid nanocarriers.

Main Results:

• Lipid nanocarriers demonstrate enhanced drug loading, controlled release, and improved tumor targeting.
• Various synthesis methods enable scalable production for diverse lipid nanocarrier formulations.
• Studies indicate reduced systemic toxicity and improved therapeutic efficacy compared to conventional methods.

Conclusions:

• Lipid nanocarriers represent a promising platform for advanced anticancer drug delivery.
• Further research into synthesis optimization and safety profiling is essential for clinical translation.
• These nanocarriers hold potential for more effective and safer cancer treatment strategies.